Øjendyreklinikken ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  11.3% 21.6% 12.1% 9.1% 8.7%  
Credit score (0-100)  21 4 19 26 28  
Credit rating  BB B BB BB BB  
Credit limit (kDKK)  0.0 -0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  -5.0 -68.0 1,273 1,653 1,917  
EBITDA  -5.0 -68.0 254 494 632  
EBIT  -5.0 -68.0 169 385 520  
Pre-tax profit (PTP)  -9.0 -74.4 149.2 377.6 521.4  
Net earnings  -7.0 -58.2 113.8 292.5 404.9  
Pre-tax profit without non-rec. items  -9.0 -74.4 149 378 521  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 417 354 272  
Shareholders equity total  33.0 -25.3 88.6 381 636  
Interest-bearing liabilities  84.5 186 381 119 0.0  
Balance sheet total (assets)  122 170 722 886 1,058  

Net Debt  45.7 113 175 -163 -488  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -5.0 -68.0 1,273 1,653 1,917  
Gross profit growth  0.0% -1,259.5% 0.0% 29.9% 16.0%  
Employees  0 0 2 3 3  
Employee growth %  0.0% 0.0% 0.0% 50.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  122 170 722 886 1,058  
Balance sheet change%  0.0% 38.7% 325.1% 22.7% 19.4%  
Added value  -5.0 -68.0 253.9 469.7 631.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 332 -172 -194  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 1.0 2.0 3.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 13.3% 23.3% 27.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -4.1% -42.8% 36.8% 47.9% 53.7%  
ROI %  -4.3% -44.7% 51.3% 78.8% 91.2%  
ROE %  -21.4% -57.4% 88.1% 124.6% 79.6%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  26.9% -13.0% 12.3% 43.0% 60.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -913.3% -165.6% 69.0% -33.1% -77.3%  
Gearing %  256.5% -737.6% 429.9% 31.3% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  9.5% 4.8% 7.0% 2.9% 1.4%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.6 12.0 0.4 0.7 1.4  
Current Ratio  0.6 12.0 0.4 0.9 1.7  
Cash and cash equivalent  38.9 73.9 205.6 282.8 488.2  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -32.4 95.9 -403.4 -38.9 284.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 127 157 211  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 127 165 211  
EBIT / employee  0 0 84 128 173  
Net earnings / employee  0 0 57 97 135